BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27967264)

  • 1. Tamoxifen Attenuates Lipopolysaccharide/Galactosamine-induced Acute Liver Failure by Antagonizing Hepatic Inflammation and Apoptosis.
    Zhang P; Zhang M; Wan M; Huang X; Jiang Y; Xu S; Luo M
    Immunol Invest; 2017 Apr; 46(3):284-294. PubMed ID: 27967264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antagonistic effect of tamoxifen against d-galactosamine/lipopolysaccharide-induced acute liver failure is associated with reactivation of hepatic nuclear factor-κB.
    Liu L; Zhao Y; Lin Y; Zhang R; Luo S; Ye P; Luo M
    Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):192-198. PubMed ID: 30721100
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen Prevents D-galactosamine/Lipopolysaccharide-Induced Murine Acute Hepatic Failure through Inhibition of Oxidative Stress and Mmd-2 Upregulation.
    Gong X; Cao P; Liu L; Lin Y; Yang Q; Zhou L; Wu T; Luo M
    Immunol Invest; 2018 Aug; 47(6):547-557. PubMed ID: 29775111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
    Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
    Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
    J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
    Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
    Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury.
    Kuhla A; Eipel C; Abshagen K; Siebert N; Menger MD; Vollmar B
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1069-76. PubMed ID: 19264954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,3'-Diindolylmethane attenuates LPS-mediated acute liver failure by regulating miRNAs to target IRAK4 and suppress Toll-like receptor signalling.
    Tomar S; Nagarkatti M; Nagarkatti PS
    Br J Pharmacol; 2015 Apr; 172(8):2133-47. PubMed ID: 25521277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoprotective effects of cathepsin B inhibitor on acute hepatic failure induced by lipopolysaccharide/D-galactosamine in mice.
    Yan BZ; Chen LY; Kang L; Wang XR; Bi MR; Wang W; Yang BS
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):80-6. PubMed ID: 23392803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice.
    Gong X; Luo FL; Zhang L; Li HZ; Wu MJ; Li XH; Wang B; Hu N; Wang CD; Yang JQ; Wan JY
    Int Immunopharmacol; 2010 Mar; 10(3):357-63. PubMed ID: 20036342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotenone, a mitochondrial respiratory complex I inhibitor, ameliorates lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice.
    Ai Q; Jing Y; Jiang R; Lin L; Dai J; Che Q; Zhou D; Jia M; Wan J; Zhang L
    Int Immunopharmacol; 2014 Jul; 21(1):200-7. PubMed ID: 24830863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
    Lee WC; Kim JK; Kang JW; Oh WY; Jung JY; Kim YS; Jung HA; Choi JS; Lee SM
    Food Chem Toxicol; 2010 Jan; 48(1):222-8. PubMed ID: 19818826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.
    Xie J; Liu J; Chen TM; Lan Q; Zhang QY; Liu B; Dai D; Zhang WD; Hu LP; Zhu RZ
    World J Gastroenterol; 2015 May; 21(18):5473-81. PubMed ID: 25987769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells.
    Lei YC; Yang LL; Li W; Luo P; Zheng PF
    World J Gastroenterol; 2015 Dec; 21(46):13055-63. PubMed ID: 26676341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
    Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The protective role of peroxisome proliferator activated receptors-α and pathomechanism in D-galactosamine/lipopolysaccharide- induced acute liver failure in rats].
    Jiao M; Ren F; Zhou L; Duan Z; Zhao C
    Zhonghua Nei Ke Za Zhi; 2014 Sep; 53(9):730-4. PubMed ID: 25511408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qingchangligan formula attenuates the inflammatory response to protect the liver from acute failure induced by d-galactosamine/lipopolysaccharide in mice.
    Zhang X; Ding J; Gou C; Wen T; Li L; Wang X; Yang H; Liu D; Lou J; Chen D; Ren F; Li X
    J Ethnopharmacol; 2017 Apr; 201():108-116. PubMed ID: 27833028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
    Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute liver injury attenuation of a novel recombinant sTNFR through blocking hepatic apoptosis.
    Luo M; Zhao A; Li J; Chen Y; Tian D; Wang C; Hu Z; Gao J
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):295-300. PubMed ID: 25982795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.